HIGHLIGHTS
- who: Yoonkyung Chang and collaborators from the Department of Neurology, Mokdong Hospital, College of Medicine, Ewha Womans University, Seoul, Republic of Korea have published the article: Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review, in the Journal: Medicina 2023, 776 of /2023/
- what: In this review, the evidence of lipid-lowering medications such as statin, ezetimibe, and PCSK9 inhibitors for secondary stroke prevention and management of dyslipidemia for each subtype of stroke is described.
- how: The trial was conducted in atherosclerotic cardiovascular disease patients (including 19% ischemic stroke patients) with LDL . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.